Multiphoton detection of dopamine and drug release

多巴胺和药物释放的多光子检测

基本信息

  • 批准号:
    8780111
  • 负责人:
  • 金额:
    $ 19.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-15 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dopamine is important in Parkinson's disease and the action of abused drugs (e.g. amphetamines) and clinical psychiatric drugs (e.g. antipsychotics). Because dopamine cannot be seen directly in living neurons with the light microscope, it is difficult to localize and quantify Ca2+-dependent vesicular and amphetamine- induced nonvesicular dopamine release from the soma, dendrites and terminals in living brain tissue. Likewise, the hypothesis that drugs accumulate in and are released from monoamine vesicles has not been tested. Such corelease of antipsychotic drugs with their target transmitters would result in concentrated drug delivery when and where drug action is needed (i.e., at active dopamine and serotonin synapses) resulting in greater efficacy and specificity. To be able to visualize dopamine and drug dynamics in living neurons, we have been developing new experimental approaches based on multiphoton microscopy in the rodent brain slice. First, we found that the clinically used anxiolytic antipsychotic drug cyamemazine produces visible fluorescence upon multiphoton excitation. Multiphoton imaging in midbrain slices showed that cyamemazine is subject to acidic trapping and Ca2+-dependent release. Second, multiphoton microscopy detected autofluorescence in substantia nigra dopamine neurons. Amphetamine induced dopamine transporter- mediated depletion of this signal. Likewise, depolarization induced Ca2+-dependent depletion. These results support the hypothesis that intrinsic multiphoton autofluorescence is derived from dopamine. This proposal builds on these preliminary results to first determine whether multiphoton microscopy in the brain slice can image a dopamine-derived signal that reveals content and release. Then the hypothesis that there is colocalized release of an antipsychotic drug with its target monoamine transmitters (i.e., dopamine and serotonin) is tested. These experiments will explore new optical approaches for studying dopamine and drugs in living brain tissue. Furthermore, determining whether there is corelease of an anxiolytic antipsychotic drug with serotonin and dopamine would be important for establishing a new paradigm for psychiatric drug action.
描述(由申请人提供):多巴胺在帕金森病以及滥用药物(例如安非他明)和临床精神药物(例如抗精神病药物)的作用中很重要。由于光显微镜无法直接在活体神经元中看到多巴胺,因此很难定位和量化活体脑组织中胞体、树突和末梢中 Ca2+ 依赖性囊泡和安非他明诱导的非囊泡多巴胺释放。同样,药物在单胺囊泡中积累和释放的假设尚未得到检验。抗精神病药物与其目标递质的这种共释放将导致在需要药物作用的时间和地点(即,在活跃的多巴胺和血清素突触)集中药物输送,从而产生更大的功效和特异性。为了能够可视化活体神经元中的多巴胺和药物动力学,我们一直在开发基于啮齿动物脑切片中的多光子显微镜的新实验方法。 首先,我们发现临床上使用的抗焦虑抗精神病药物氰胺嗪在多光子激发下产生可见荧光。中脑切片的多光子成像表明氰尿嗪会受到酸性捕获和 Ca2+ 依赖性释放。其次,多光子显微镜检测到黑质多巴胺神经元的自发荧光。安非他明诱导多巴胺转运蛋白介导的该信号的消耗。同样,去极化诱导 Ca2+ 依赖性消耗。这些结果支持了固有多光子自发荧光源自多巴胺的假设。 该提议建立在这些初步结果的基础上,首先确定大脑切片中的多光子显微镜是否可以对揭示内容和释放的多巴胺衍生信号进行成像。然后假设抗精神病药物与其目标单胺递质(即, 多巴胺和血清素)进行了测试。这些实验将探索新的光学方法来研究活体脑组织中的多巴胺和药物。此外,确定抗焦虑抗精神病药物是否与血清素和多巴胺共同释放对于建立精神科药物作用的新范例非常重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWIN S LEVITAN其他文献

EDWIN S LEVITAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWIN S LEVITAN', 18)}}的其他基金

A New Method for Imaging Neuropeptide Release in the Brain
大脑中神经肽释放成像的新方法
  • 批准号:
    10016856
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
Endoplasmic Reticulum NAD(P)H Dynamics in Dopamine Neurons
多巴胺神经元内质网 NAD(P)H 动力学
  • 批准号:
    9750034
  • 财政年份:
    2018
  • 资助金额:
    $ 19.25万
  • 项目类别:
Antipsychotic Drug Vesicular Release at Dopamine Synapses
多巴胺突触的抗精神病药物囊泡释放
  • 批准号:
    9125571
  • 财政年份:
    2016
  • 资助金额:
    $ 19.25万
  • 项目类别:
Antipsychotic Drug Vesicular Release at Dopamine Synapses
多巴胺突触的抗精神病药物囊泡释放
  • 批准号:
    9273637
  • 财政年份:
    2016
  • 资助金额:
    $ 19.25万
  • 项目类别:
Multiphoton Monoamine Imaging of Serotonin Neuron Function
血清素神经元功能的多光子单胺成像
  • 批准号:
    7674555
  • 财政年份:
    2008
  • 资助金额:
    $ 19.25万
  • 项目类别:
Multiphoton Monoamine Imaging of Serotonin Neuron Function
血清素神经元功能的多光子单胺成像
  • 批准号:
    7570447
  • 财政年份:
    2008
  • 资助金额:
    $ 19.25万
  • 项目类别:
Long-Term Regulation of Potassium Channels
钾通道的长期调节
  • 批准号:
    7047452
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Dopamine Neuron Excitability
多巴胺神经元兴奋性的调节
  • 批准号:
    7390292
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Cardiac Kv Channel Expression
心脏 Kv 通道表达的调节
  • 批准号:
    8442902
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Cardiac Kv Channel Expression
心脏 Kv 通道表达的调节
  • 批准号:
    8258221
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:

相似海外基金

Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
  • 批准号:
    25860103
  • 财政年份:
    2013
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
  • 批准号:
    22659138
  • 财政年份:
    2010
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8312648
  • 财政年份:
    2010
  • 资助金额:
    $ 19.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8531900
  • 财政年份:
    2010
  • 资助金额:
    $ 19.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8715749
  • 财政年份:
    2010
  • 资助金额:
    $ 19.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8144930
  • 财政年份:
    2010
  • 资助金额:
    $ 19.25万
  • 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
  • 批准号:
    7675601
  • 财政年份:
    2009
  • 资助金额:
    $ 19.25万
  • 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
  • 批准号:
    17590585
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
  • 批准号:
    17590588
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
  • 批准号:
    6870119
  • 财政年份:
    2004
  • 资助金额:
    $ 19.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了